Ran Geng is a Director at OrbiMed, an investment firm that focuses on biotech companies with a clear path to disrupt treatment paradigm of diseases and technologies that address the inequality of healthcare resources or inefficiency of healthcare delivery. Geng helps companies reduce development costs.